Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India

 
By rejecting patent applications, developing countries have kept down the costs of much-needed medications. Can they continue to do so without harming efforts to develop new drugs?
Read More >>

By Thomas Bollyky

Posted by alias inkhorn




No comments:

Post a Comment